Fundraising Fox

Circular Genomics

Albuquerque, US · Founded 2021 · Delaware corporation · 3 known investors

circulargenomics.com ↗

Circular Genomics develops a proprietary platform using circular RNA biomarkers to enable early detection and understanding of neurological diseases through blood tests. The company serves researchers, clinicians, and biopharma partners with diagnostic tools for conditions like Alzheimer's and Parkinson's.

AI & Machine LearningBiotechDigital HealthMedical Devicesin /circulargenomics@CircGenomics

Founders & leadership

AH
Alexander HafezExecutive Officer, Director, Promoter
NM
Nikolaos MelliosDirector, Promoter

Investors · 3

Cottonwood Technology FundSanta Fe · $1M – $25M
Mountain Group CapitalNashville
Tramway Venture PartnersreportedNew Mexico · $30M

Reported raises · per SEC filings

Form D private placements
▶$8.3MraisedJan 2024 · 9 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Fortunado RoccaDirector
  • David BlivinDirector
  • Paul SargeantExecutive Officer, Director
  • Waneta TuttleDirector
  • Nikolaos MelliosDirector
  • Joseph Cook IIIDirector
Offering amount
$15M
Amount sold
$8.3M
Minimum investment
$100K
First sale
Jan 2024
Incorporated
Corporation, Delaware, 2021
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$3.1MraisedMar 2023 · 7 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Stephen McKernanExecutive Officer
  • Cathy PettiDirector
  • Blivin DavidDirector
  • Fortunado RoccaDirector
  • Alexander HafezExecutive Officer, Director, Promoter
  • Nikolaos MelliosExecutive Officer, Director, Promoter
  • Paul SargeantExecutive Officer, Director
  • Joseph Cook IIIDirector
  • Waneta TuttleDirector
Offering amount
$3.2M
Amount sold
$3.1M
Proceeds to insiders
$850K
First sale
Nov 2021
Incorporated
Corporation, Delaware, 2021
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$1.2MraisedAug 2021 · 7 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Alexander HafezExecutive Officer, Director, Promoter
  • Nikolaos MelliosDirector, Promoter
Offering amount
$2M
Amount sold
$1.2M
Proceeds to insiders
$300K
First sale
Aug 2021
Incorporated
Corporation, Delaware, 2021
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news